SEC CIK 1658944
Matlin Laura
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| BRview stock → | 6,342.7 | 2025-04-01 |
Position History — BR
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — BR
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2025-04-01 | Tax withholding | 259 | $244.72 | 6,342.7 |
| 2025-02-04 | Grant / award (derivative) | 1,580 | $0.00 | 1,580 |
| 2025-02-04 | Open-market sale | 514 | $241.60 | 6,601.7 |
| 2024-11-12 | Option exercise (derivative) | 3,888 | $0.00 | 0 |
| 2024-11-12 | Open-market sale | 3,459 | $227.65 | 7,115.7 |
| 2024-11-12 | Open-market sale | 3,351 | $227.65 | 10,574.7 |
| 2024-11-12 | Option exercise | 3,888 | $98.31 | 13,925.7 |
| 2024-11-12 | Option exercise | 3,920 | $117.34 | 10,037.7 |
| 2024-08-13 | Grant / award | 588 | $0.00 | 6,117.7 |
| 2024-08-08 | Open-market sale | 673 | $216.00 | 5,529.7 |
| 2024-04-01 | Tax withholding | 278 | $203.23 | 6,202.7 |
| 2024-02-15 | Grant / award (derivative) | 1,895 | $0.00 | 1,895 |
| 2023-12-08 | Option exercise (derivative) | 4,178 | $0.00 | 0 |
| 2023-12-08 | Option exercise | 4,178 | $93.88 | 10,570.7 |
| 2023-12-08 | Open-market sale | 426 | $189.49 | 10,144.7 |
| 2023-12-08 | Open-market sale | 3,664 | $189.49 | 6,480.7 |
| 2023-08-15 | Grant / award | 568 | $0.00 | 6,392.7 |
| 2023-05-19 | Option exercise (derivative) | 4,725 | $0.00 | 0 |
| 2023-05-19 | Option exercise | 4,725 | $67.32 | 9,876.7 |
| 2023-05-19 | Open-market sale | 4,052 | $153.73 | 5,824.7 |
| 2023-04-01 | Tax withholding | 466 | $146.57 | 5,151.7 |
| 2023-02-15 | Grant / award (derivative) | 2,714 | $0.00 | 2,714 |
| 2022-08-17 | Open-market sale | 2,067 | $177.81 | 5,617.7 |
| 2022-08-10 | Grant / award | 964 | $0.00 | 7,684.7 |
| 2022-04-01 | Tax withholding | 394 | $156.31 | 6,720.7 |
| 2022-02-14 | Grant / award (derivative) | 2,607 | $0.00 | 2,607 |
| 2021-08-09 | Grant / award | 820 | $0.00 | 7,114.7 |
| 2021-08-09 | Grant / award | 820 | $0.00 | 7,114.7 |
| 2021-05-20 | Open-market sale | 1,369 | $160.05 | 6,294.7 |
| 2021-04-01 | Tax withholding | 411 | $154.92 | 7,663.7 |
| 2021-02-12 | Grant / award (derivative) | 3,071 | $0.00 | 3,071 |
| 2020-08-04 | Grant / award | 859 | $0.00 | 8,074.7 |
| 2020-05-20 | Open-market sale | 862 | $122.16 | 7,215.7 |
| 2020-05-19 | Option exercise (derivative) | 7,230 | $0.00 | 0 |
| 2020-05-19 | Open-market sale | 6,138 | $119.91 | 8,077.7 |
| 2020-05-19 | Option exercise | 7,230 | $51.95 | 13,938.7 |
| 2020-05-19 | Option exercise | 1,806 | $50.95 | 15,744.7 |
| 2020-05-19 | Open-market sale | 1,529 | $119.91 | 14,215.7 |
| 2020-04-01 | Tax withholding | 657 | $91.32 | 6,708.7 |
| 2020-02-04 | Grant / award (derivative) | 3,920 | $0.00 | 3,920 |
| 2019-08-06 | Grant / award | 1,378 | $0.00 | 7,365.7 |
| 2019-05-14 | Open-market sale | 3,875 | $118.99 | 5,987.7 |
| 2019-04-01 | Tax withholding | 802 | $104.99 | 9,862.7 |
| 2019-02-11 | Grant / award (derivative) | 3,888 | $0.00 | 3,888 |
| 2018-08-02 | Grant / award | 1,664 | $0.00 | 10,664.7 |
| 2018-05-11 | Open-market sale | 897 | $118.06 | 10,043.7 |
| 2018-05-11 | Open-market sale | 1,043 | $117.95 | 9,000.7 |
| 2018-04-02 | Option exercise (derivative) | 1,513 | $0.00 | 0 |
| 2018-04-02 | Tax withholding | 692 | $109.69 | 11,782.7 |
| 2018-04-02 | Tax withholding | 842 | $109.69 | 10,940.7 |
| 2018-04-02 | Option exercise | 1,513 | $0.00 | 12,474.7 |
| 2018-02-14 | Option exercise (derivative) | 5,416 | $0.00 | 1,806 |
| 2018-02-14 | Option exercise (derivative) | 10,351 | $0.00 | 0 |
| 2018-02-14 | Option exercise (derivative) | 1,574 | $0.00 | 4,725 |
| 2018-02-14 | Option exercise (derivative) | 7,230 | $95.76 | 7,230 |
| 2018-02-14 | Option exercise | 4,429 | $36.97 | 34,512.7 |
| 2018-02-14 | Option exercise | 10,351 | $36.97 | 17,437.7 |
| 2018-02-14 | Option exercise | 7,230 | $51.95 | 24,667.7 |
| 2018-02-14 | Option exercise | 5,416 | $50.95 | 30,083.7 |
| 2018-02-14 | Option exercise | 1,574 | $67.32 | 36,086.7 |
| 2018-02-14 | Open-market sale | 25,125 | $95.76 | 10,961.7 |
| 2018-02-12 | Grant / award (derivative) | 4,178 | $0.00 | 4,178 |
| 2017-08-02 | Grant / award | 1,816 | $0.00 | 7,086.7 |
| 2017-05-15 | Open-market sale | 630 | $71.89 | 5,270.7 |
| 2017-04-03 | Option exercise (derivative) | 1,212 | $0.00 | 0 |
| 2017-04-03 | Option exercise | 1,212 | $0.00 | 6,772.7 |
| 2017-04-03 | Tax withholding | 455 | $67.95 | 5,900.7 |
| 2017-04-03 | Tax withholding | 417 | $67.95 | 6,355.7 |
| 2017-02-10 | Grant / award (derivative) | 6,299 | $0.00 | 6,299 |
| 2016-08-12 | Open-market sale | 900 | $68.51 | 5,560.7 |
| 2016-08-02 | Grant / award | 1,333 | $0.00 | 6,460.7 |
| 2016-04-01 | Option exercise (derivative) | 1,647 | $0.00 | 0 |
| 2016-04-01 | Tax withholding | 792 | $59.42 | 5,127.7 |
| 2016-04-01 | Tax withholding | 560 | $59.42 | 5,919.7 |
| 2016-04-01 | Option exercise | 1,647 | $0.00 | 6,479.7 |
| 2016-02-08 | Grant / award (derivative) | 14,460 | $0.00 | 14,460 |
| 2015-11-12 | — | — | — | 4,832.7 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.